Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers

Phase 1 Completed 56 enrolled Celon Pharma SA National Center for Research and Development, Poland · collab

RandomizedSequentialDouble-blindTreatment

Summary

The planned study is to determine the safety and pharmacokinetic properties of CPL500036 compound after single and multiple (two weeks) administration in healthy volunteers.

Timeline

Start: 2018-12-20
Primary completion: 2019-09-16
Completion: 2019-09-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CPL500036	Unknown	—	Oral

Indications

No indication recorded.